Publications by authors named "B C Garden"
Article Synopsis
- Hidradenitis suppurativa (HS) is a skin condition driven by overactive Th1 and Th17 cells that has shown improvement with biologic treatments, though many lack sufficient clinical trial support.
- Adalimumab is currently the only biologic approved by the FDA specifically for HS, while other therapies are being explored to target its inflammatory pathways.
- A case study involving a patient with both atopic dermatitis and HS showed improvement with dupilumab, a drug known for targeting Th2 inflammation, highlighting the complexities and need for more research on the inflammatory mechanisms of HS.
Objective: To describe our technique and early results for inflatable penile prosthesis (IPP) deactivation via puncture and drainage in the office setting to avoid penile explanting interventions in high-risk surgical patients.
Methods: A retrospective chart review of patients with high perioperative risk who had undergone IPP prosthesis puncture in the office setting between March 2020 and May 2021 was performed. Variables included age, the reason for penile prosthesis implantation and deactivation, time frame from implantation to deactivation, type of penile implant, follow-up time, and complications.
Background And Objective: Keloids are benign lesions arising from overproduction of the extracellular matrix and abnormal collagen deposition by dermal fibroblasts. This altered wound healing typically occurs in response to dermal trauma. Keloid treatment poses a challenge due to the variable nature of treatment response, which can be affected by the size, appearance, and associated symptoms of erythema, pruritus, and pain.
View Article and Find Full Text PDFBackground: Acne vulgaris remains a challenging disease to treat in many patients. Traditional therapies may have limited successes with potential side effects. Laser and light energy devices may offer a desirable alternative.
View Article and Find Full Text PDF